tarextumab

·Code: OMP-59R5

tarextumab: developed by 1 company. Updated within the last hour.

Development Pipeline (1)

CompanyPhase
OncoMed Pharmaceuticals Inc (OMED)Phase 2

Get deeper analysis on tarextumab

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    tarextumab — Drug Pipeline, Trials & FDA Status | BioSniper